Dr. Yang Liu
DY
Dr. Yang Liu
CTO & Co-Founder
Rate
About
Dr. Yang Liu is a leading cancer immunologist and a successful entrepreneur. He co-founded OncoImmune, Inc. in 2000, leading it until its acquisition by Merck, Inc. in 2020. In December 2020, he co-founded OncoC4, Inc., where he currently serves as Chairman, CEO, and CSO. Dr. Liu has published over 200 peer-reviewed publications and holds numerous patent applications.
Frequently asked
Who is Dr. Yang Liu?
Dr. Yang Liu is a leading cancer immunologist and a successful entrepreneur. He co-founded OncoImmune, Inc. in 2000, leading it until its acquisition by Merck, Inc. in 2020. In December 2020, he co-founded OncoC4, Inc., where he currently serves as Chairman, CEO, and CSO. Dr. Liu has published over 200 peer-reviewed publications and holds numerous patent applications.
What is Dr. Yang Liu's current role?
Dr. Yang Liu is currently CTO & Co-Founder.
Comments
No comments yet. Be the first to share your take.
Profile
About Dr. Yang Liu
Dr. Yang Liu is CTO & Co-Founder. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.